安迪苏：关于公司2025年第四季度的经营情况，公司将在2025年年度报告中予以披露

Core Viewpoint - The company anticipates stable growth in its business operations, with a reported revenue increase of 14% year-on-year for the first three quarters of 2025, amounting to RMB 12.93 billion [1] Financial Performance - The company's revenue for the first three quarters of 2025 reached RMB 12.93 billion, reflecting a 14% year-on-year growth [1] - Gross profit increased by 4% to RMB 3.6 billion, driven by the rising penetration of liquid amino acids and double-digit sales growth in specialty products [1] Market Dynamics - The market demand is expected to remain strong; however, the entry of new methionine and vitamin production capacity into the market is intensifying industry competition [1] - The company is committed to supporting business growth and will continue to invest for future expansion [1] Communication and Disclosure - The company emphasizes adherence to information disclosure regulations, ensuring that all significant information is released through designated channels in a timely and accurate manner [1] - Investors are encouraged to monitor company announcements and periodic reports for authoritative operational data [1]